# Correction: Bevacizumab improved prognosis for advanced EGFR-mutant lung adenocarcinoma with brain metastasis receiving cerebral radiotherapy

**Authors:** Yuanliang Zhou, Jingchao Li, Yankang Li, Guangchuan Deng, Qi Wang, Hongyue Qin, Jianbin Li, Zhenxiang Li

PMC · DOI: 10.1007/s12094-025-03867-4 · Clinical & Translational Oncology · 2025-02-13

## Full-text entities

- **Genes:** EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}
- **Diseases:** brain metastasis (MESH:D009362), lung adenocarcinoma (MESH:D000077192)
- **Chemicals:** Bevacizumab (MESH:D000068258)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12000119/full.md

---
Source: https://tomesphere.com/paper/PMC12000119